You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Early myelofibrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Unknown status
  • Essential Thrombocythemia
  • +2 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Sep 27, 2020

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Myelofibrosis Trial in United States (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Boston, Massachusetts
  • +4 more
Oct 21, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Myelofibrosis Trial in Houston (CK0804)

Not yet recruiting
  • Myelofibrosis
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 28, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

Completed
  • Primary Myelofibrosis
  • Anemia
  • Phoenix, Arizona
  • +24 more
Aug 17, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated
  • Myelofibroses
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 16, 2021

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

Philadelphia Negative Myeloproliferative Tumors Trial

Not yet recruiting
  • Philadelphia Negative Myeloproliferative Neoplasms
    • (no location specified)
    Jun 5, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +121 more
    Oct 21, 2021

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Feb 10, 2022

    Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Jul 9, 2021

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Hyperbaric oxygen
    • Rochester, New York
      Wilmot Cancer Institute, University of Rochester
    May 16, 2022

    68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

    Recruiting
    • Primary Myelofibrosis
    • 68Ga FAPI PET/CT
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

    Not yet recruiting
    • Bone Marrow Fibrosis
    • Myeloproliferative Neoplasm
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jan 30, 2023

    Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Rochester, Minnesota
      (unnamed)
    Aug 24, 2021

    Assess the Safety of Fedratinib in Korean Myelofibrosis

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Myelofibrosis Trial (Momelotinib)

    Available
    • Myelofibrosis
    • (no location specified)
    Oct 12, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Myelofibrosis With High Molecular Risk Mutations Trial in Worldwide (Ruxolitinib, Ruxolitinib Placebo)

    Terminated
    Has Results
    • Myelofibrosis With High Molecular Risk Mutations
    • Concord NSW, New South Wales, Australia
    • +109 more
    Jul 8, 2019